Dr. Brenda M Vozza , MD
Internal Medicine • Longview, TX
300 N 3rd St
Longview, TX 756016505
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Brenda Vozza is listed in NPPES under Internal Medicine.
-
NPI assigned on May 17, 2006; this date does not establish years in practice.
-
Published CMS data list 10,083 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 36415 — Insertion of needle into vein for collection of blood sample: 877 service units.
- 80048 — Blood test, basic group of blood chemicals (calcium, total): 801 service units.
- 85025 — Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count: 726 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 58 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 22,724 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Atorvastatin Calcium — 1,165 prescription fills, including refills.
- Amlodipine Besylate — 966 prescription fills, including refills.
- Losartan Potassium — 927 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 233 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in Longview, TX (2024, 71 clinicians with data). Median for this group: 737. Middle half: 357 to 1,308.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 10,233 in 2020 to 10,083 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
300 N 3rd St
Longview, TX 756016505
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Brookridge Internal Medicine Associates, Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Albert Einstein College Of Medicine Of Yeshiva University
1998
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
516 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $428,821 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $340,221 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
42,052 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$2,613,120 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,848.32 across 86 records.
By nature of payment
- Food and Beverage: $1,673.32 across 85 records.
- Consulting Fee: $175.00 across 1 record.
Reporting-company totals (3 largest of 21)
- Bayer Healthcare Pharmaceuticals Inc.: $446.06 across 17 records.
- Amgen Inc.: $227.05 across 7 records.
- AstraZeneca Pharmaceuticals LP: $226.26 across 11 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
28 years (graduated 1998)
CMS Doctors and Clinicians data list 1998 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Vozza has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Vozza as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Longview and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in Longview, TX (2024, 71 clinicians with data). Median for this group: 737. Middle half: 357 to 1,308.
More Medicare Part B services than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: 645. Middle half: 277 to 1,322.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Longview, TX (2024, 71 clinicians with data). Median for this group: $75,959. Middle half: $36,872 to $125,310.
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $61,221. Middle half: $27,420 to $115,826.
Paid by Medicare
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Longview, TX (2024, 71 clinicians with data). Median for this group: $59,761. Middle half: $27,621 to $95,833.
A higher Medicare payment amount than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,423 clinicians with data). Median for this group: $47,501. Middle half: $20,446 to $90,051.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Longview, TX (2024, 78 clinicians with data). Median for this group: 256. Middle half: 92 to 6,437.
More Part D prescriptions than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: 828. Middle half: 121 to 4,824.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Longview, TX (2024, 78 clinicians with data). Median for this group: $15,088. Middle half: $1,085 to $464,881.
A higher Part D drug cost than 95% of clinicians listed under Internal Medicine in Texas (2024, 5,674 clinicians with data). Median for this group: $64,859. Middle half: $4,211 to $436,775.
99 active clinicians are listed under Internal Medicine with a practice address in Longview, TX (9,191 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Longview
20.2% of these 99 clinicians have the CMS telehealth indicator.
76.8% of these 99 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 10,233 in 2020 and 10,083 in 2024.
- 2020: 10,233
- 2021: 11,834
- 2022: 12,417
- 2023: 12,300
- 2024: 10,083
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $438,224 in 2020 and $428,821 in 2024.
- 2020: $438,224
- 2021: $483,206
- 2022: $571,368
- 2023: $571,618
- 2024: $428,821
-
Paid by Medicare
Paid by Medicare varied from year to year: $350,160 in 2020 and $340,221 in 2024.
- 2020: $350,160
- 2021: $386,793
- 2022: $453,877
- 2023: $457,943
- 2024: $340,221
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 13% from 26,098 in 2020 to 22,724 in 2024.
- 2020: 26,098
- 2021: 28,798
- 2022: 22,746
- 2023: 21,642
- 2024: 22,724
-
30-day fills
30-day fills stayed about the same: 42,374 in 2020 and 42,052 in 2024.
- 2020: 42,374
- 2021: 48,039
- 2022: 41,372
- 2023: 40,249
- 2024: 42,052
-
Part D drug cost
Part D drug cost increased 35% from $1,932,617 in 2020 to $2,613,120 in 2024.
- 2020: $1,932,617
- 2021: $2,084,978
- 2022: $2,015,078
- 2023: $2,271,097
- 2024: $2,613,120
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 18% from $2,241.47 in 2021 to $1,848.32 in 2025.
- 2021: $2,241.47
- 2022: $2,132.02
- 2023: $2,157.34
- 2024: $1,933.67
- 2025: $1,848.32
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 86 records totaling $1,848.32.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Amgen Inc. |
Consulting Fee
Cash or cash equivalent
|
PROLIA | General | $175.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $82.58 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $59.06 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) |
Food and Beverage
In-kind items and services
|
CAPLYTA | General | $47.54 |
| Stryker Corporation |
Food and Beverage
In-kind items and services
|
CLARIFIX | General | $39.70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
JASCAYD | General | $29.66 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.47 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.47 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $29.20 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.96 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.98 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $24.32 |
| Abbott Laboratories |
Food and Beverage
In-kind items and services
|
FREESTYLE LIBRE 3 | General | $22.85 |
| Dexcom, Inc. |
Food and Beverage
In-kind items and services
|
Dexcom G6 Transmitter | General | $22.58 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $22.52 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $21.93 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
REXULTI | General | $21.90 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $21.52 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $21.47 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.98 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $20.91 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
BREZTRI | General | $20.86 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
VRAYLAR | General | $20.76 |
| Sumitomo Pharma America, Inc. |
Food and Beverage
In-kind items and services
|
GEMTESA | General | $20.68 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $20.04 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
36415
Insertion of needle into vein for collection of blood sample
|
877 | 297 | $22.00 | $8.65 |
|
80048
Blood test, basic group of blood chemicals (calcium, total)
|
801 | 296 | $76.00 | $8.28 |
|
85025
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
|
726 | 291 | $51.00 | $7.60 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
623 | 230 | $166.00 | $121.68 |
|
80076
Liver function blood test panel
|
622 | 265 | $67.00 | $8.00 |
|
80061
Blood test, lipids (cholesterol and triglycerides)
|
612 | 273 | $103.00 | $13.09 |
|
83036
Hemoglobin a1c level
|
403 | 180 | $69.00 | $9.57 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
391 | 214 | $109.00 | $86.10 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
387 | 104 | $156.00 | $74.59 |
|
99457
Management using the results of remote vital sign monitoring per calendar month, first 20 minutes
|
375 | 63 | $159.84 | $46.46 |
|
99458
Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes
|
243 | 44 | $130.00 | $37.50 |
|
82044
Urine microalbumin (protein) analysis
|
240 | 115 | $40.00 | $6.18 |
|
99490
Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
|
238 | 39 | $130.00 | $59.83 |
|
99309
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes
|
213 | 63 | $161.00 | $102.67 |
|
82570
Creatinine level to test for kidney function or muscle injury
|
212 | 105 | $55.00 | $5.08 |
|
G0442
Annual alcohol misuse screening, 5 to 15 minutes
|
189 | 189 | $0.01 | $0.01 |
|
84443
Blood test, thyroid stimulating hormone (tsh)
|
184 | 100 | $104.00 | $16.38 |
|
G0444
Annual depression screening, 5 to 15 minutes
|
176 | 176 | $36.00 | $17.84 |
|
82306
Vitamin d-3 level
|
172 | 128 | $88.00 | $28.87 |
|
G0439
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
|
172 | 172 | $190.00 | $123.55 |
|
93923
Complete ultrasound study of arm and leg arteries
|
168 | 79 | $280.00 | $121.57 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
166 | 34 | $17.00 | $0.94 |
|
99308
Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, 20 minutes or more
|
165 | 52 | $130.00 | $70.97 |
|
99439
Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
|
152 | 35 | $95.00 | $45.71 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
114 | 34 | $208.00 | $111.95 |
(top 25 shown)
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1,165 | 78,624 | $9,937.88 | 310 |
| Amlodipine Besylate | Amlodipine Besylate | 966 | 61,533 | $4,962.81 | 245 |
| Losartan Potassium | Losartan Potassium | 927 | 56,935 | $8,554.35 | 220 |
| Levothyroxine Sodium | Levothyroxine Sodium | 744 | 44,008 | $6,921.48 | 155 |
| Pantoprazole Sodium | Pantoprazole Sodium | 696 | 45,649 | $6,277.84 | 197 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 552 | 39,592 | $6,654.45 | 160 |
| Gabapentin | Gabapentin | 521 | 25,869 | $8,724.92 | 133 |
| Hydrochlorothiazide | Hydrochlorothiazide | 521 | 35,823 | $2,624.81 | 157 |
| Duloxetine Hcl | Duloxetine Hcl | 487 | 27,206 | $11,965.70 | 129 |
| Potassium Chloride | Potassium Chloride | 468 | 26,502 | $6,810.66 | 113 |
| Metoprolol Succinate | Metoprolol Succinate | 424 | 29,098 | $4,911.84 | 118 |
| Lisinopril | Lisinopril | 404 | 28,659 | $3,485.86 | 116 |
| Furosemide | Furosemide | 403 | 19,576 | $2,393.85 | 95 |
| Jardiance | Empagliflozin | 398 | 16,806 | $336,391.01 | 96 |
| Trazodone Hcl | Trazodone Hcl | 392 | 21,050 | $2,658.57 | 100 |
| Donepezil Hcl | Donepezil Hcl | 381 | 22,492 | $3,650.60 | 107 |
| Metoprolol Tartrate | Metoprolol Tartrate | 356 | 19,815 | $2,277.11 | 82 |
| Hydralazine Hcl | Hydralazine Hcl | 322 | 18,020 | $3,993.05 | 79 |
| Pravastatin Sodium | Pravastatin Sodium | 319 | 24,454 | $3,105.75 | 85 |
| Fluticasone Propionate | Fluticasone Propionate | 310 | 15,809 | $4,436.96 | 126 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 290 | 9,109 | $7,906.89 | 110 |
| Metformin Hcl | Metformin Hcl | 288 | 17,804 | $1,963.59 | 83 |
| Clopidogrel | Clopidogrel Bisulfate | 267 | 15,477 | $2,463.70 | 61 |
| Tramadol Hcl | Tramadol Hcl | 259 | 4,615 | $1,514.81 | 51 |
| Eliquis | Apixaban | 250 | 8,644 | $173,059.11 | 48 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-10-07NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20100716000721
TX
3476561622
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Brookridge Internal Medicine Associates, Pa
300 N 3rd St, Longview, TX 756016505
Phone: 9033152907
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Primary Care
Family Nurse Practitioner
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 300 N 3RD ST, LONGVIEW, TX 756016505 (Tel: 9033152907)
Registered at 300 N 3RD ST, LONGVIEW, TX 756016505 (Tel: 9033152907)
NPI status registered as active in NPPES database
Registered at 100 ZEID BLVD, SUITE A, HENDERSON, TX 756526069 (Tel: 9036551153)
Registered at 100 ZEID BLVD, SUITE A, HENDERSON, TX 756526069 (Tel: 9036551153)
Recorded as BRENDA VOZZA, MD
Internal Medicine (license number reported to NPPES: TX K6399)
NPI status registered as active in NPPES database
Registered at 100 ZEID BLVD, SUITE A, HENDERSON, TX 756526069 (Tel: 9036551153)
Registered at 100 ZEID BLVD, SUITE A, HENDERSON, TX 756526069 (Tel: 9036551153)
Recorded as BRENDA VOZZA ZEID, MD
Internal Medicine (license number reported to NPPES: TX K6399)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Longview
- Dr. Khamis Shalabi, MD
- Dr. Foram Thakkar, MD
- Dr. Allessia Wilson, MD
- Dr. Srinivas Rangu, MD
- Dr. Reham Youssef, MD
- Dr. Laura Welch, MD
Mailing Address
300 N 3rd St
Longview, TX 756016505
Phone: 9033152907